tiprankstipranks
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS

OrthoPediatrics Stock Analysis & Ratings

KIDS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$36.71 - $73.91
Previous Close$42.9
Volume130.82K
Average Volume (3M)121.18K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-55.4
Beta1.20
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score7


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

KIDS FAQ

What was OrthoPediatrics’s price range in the past 12 months?
OrthoPediatrics lowest stock price was $36.70 and its highest was $73.91 in the past 12 months.
    What is OrthoPediatrics’s market cap?
    Currently, no data Available
    What is OrthoPediatrics’s price target?
    The average price target for OrthoPediatrics is $61.17. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $77.00 ,the lowest forecast is $54.00. The average price target represents 42.59% Increase from the current price of $42.9.
      What do analysts say about OrthoPediatrics?
      OrthoPediatrics’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
        When is OrthoPediatrics’s upcoming earnings report date?
        OrthoPediatrics’s upcoming earnings report date is Aug 10, 2022 which is in 38 days.
          How were OrthoPediatrics’s earnings last quarter?
          OrthoPediatrics released its earnings results on May 04, 2022. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.355 by $0.055.
            Is OrthoPediatrics overvalued?
            According to Wall Street analysts OrthoPediatrics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does OrthoPediatrics pay dividends?
              OrthoPediatrics does not currently pay dividends.
              What is OrthoPediatrics’s EPS estimate?
              OrthoPediatrics’s EPS estimate is -$0.19.
                How many shares outstanding does OrthoPediatrics have?
                OrthoPediatrics has 20,229,900 shares outstanding.
                  What happened to OrthoPediatrics’s price movement after its last earnings report?
                  OrthoPediatrics reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.355. Following the earnings report the stock price went down -10.484%.
                    Which hedge fund is a major shareholder of OrthoPediatrics?
                    Among the largest hedge funds holding OrthoPediatrics’s share is Royce & Associates LLC. It holds OrthoPediatrics’s shares valued at 8M.

                      ---

                      OrthoPediatrics Stock Analysis

                      The OrthoPediatrics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      OrthoPediatrics Corp

                      OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Rhythm Pharmaceuticals
                      SeaSpine Holdings
                      Quanterix
                      Odonate Therapeutics
                      Krystal Biotech

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis